These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Preliminary experience with alemtuzumab induction therapy combined with maintenance low-dose tacrolimus monotherapy in small-bowel transplantation in China. Yuan-Xin L; Ning L; You-Sheng L; Xiao-Dong N; Ming L; Jian W; Jie-Shou L Transplant Proc; 2010; 42(1):29-34. PubMed ID: 20172275 [TBL] [Abstract][Full Text] [Related]
23. Alemtuzumab induction and prednisone-free maintenance immunotherapy in kidney transplantation: comparison with basiliximab induction--long-term results. Kaufman DB; Leventhal JR; Axelrod D; Gallon LG; Parker MA; Stuart FP Am J Transplant; 2005 Oct; 5(10):2539-48. PubMed ID: 16162205 [TBL] [Abstract][Full Text] [Related]
24. A randomized trial of thymoglobulin vs. alemtuzumab (with lower dose maintenance immunosuppression) vs. daclizumab in renal transplantation at 24 months of follow-up. Ciancio G; Burke GW; Gaynor JJ; Roth D; Kupin W; Rosen A; Cordovilla T; Tueros L; Herrada E; Miller J Clin Transplant; 2008; 22(2):200-10. PubMed ID: 18339140 [TBL] [Abstract][Full Text] [Related]
25. Outcome of patients with preformed donor-specific antibodies following alemtuzumab induction and tacrolimus monotherapy. Willicombe M; Brookes P; Santos-Nunez E; Galliford J; Ballow A; Mclean A; Roufosse C; Cook HT; Dorling A; Warrens AN; Cairns T; Taube D Am J Transplant; 2011 Mar; 11(3):470-7. PubMed ID: 21299828 [TBL] [Abstract][Full Text] [Related]
26. Early and limited use of tacrolimus to avoid rejection in an alemtuzumab and sirolimus regimen for kidney transplantation: clinical results and immune monitoring. Knechtle SJ; Pascual J; Bloom DD; Torrealba JR; Jankowska-Gan E; Burlingham WJ; Kwun J; Colvin RB; Seyfert-Margolis V; Bourcier K; Sollinger HW Am J Transplant; 2009 May; 9(5):1087-98. PubMed ID: 19344431 [TBL] [Abstract][Full Text] [Related]
27. Alemtuzumab induction in deceased donor kidney transplantation. Shin M; Song SH; Kim JM; Kwon CH; Joh JW; Lee SK; Kim SJ Transplant Proc; 2011; 43(6):2365-78. PubMed ID: 21839271 [TBL] [Abstract][Full Text] [Related]
28. Alemtuzumab induction in deceased donor kidney transplantation. Huang E; Cho YW; Hayashi R; Bunnapradist S Transplantation; 2007 Oct; 84(7):821-8. PubMed ID: 17984833 [TBL] [Abstract][Full Text] [Related]
29. A randomized trial of three renal transplant induction antibodies: early comparison of tacrolimus, mycophenolate mofetil, and steroid dosing, and newer immune-monitoring. Ciancio G; Burke GW; Gaynor JJ; Carreno MR; Cirocco RE; Mathew JM; Mattiazzi A; Cordovilla T; Roth D; Kupin W; Rosen A; Esquenazi V; Tzakis AG; Miller J Transplantation; 2005 Aug; 80(4):457-65. PubMed ID: 16123718 [TBL] [Abstract][Full Text] [Related]
30. Alemtuzumab induction in kidney transplantation. Huang E; Cho YW; Shah T; Peng A; Hayashi R; Bunnapradist S Clin Transpl; 2005; ():343-54. PubMed ID: 17424750 [TBL] [Abstract][Full Text] [Related]
31. Alemtuzumab preconditioning with tacrolimus monotherapy-the impact of serial monitoring for donor-specific antibody. Shapiro R; Zeevi A; Basu A; Tan HP; Kayler LK; Blisard DM; Thai NL; Girnita AL; Randhawa PS; Gray EA; Marcos A; Starzl TE Transplantation; 2008 Apr; 85(8):1125-32. PubMed ID: 18431232 [TBL] [Abstract][Full Text] [Related]
32. Use of alemtuzumab and tacrolimus monotherapy for cadaveric liver transplantation: with particular reference to hepatitis C virus. Marcos A; Eghtesad B; Fung JJ; Fontes P; Patel K; Devera M; Marsh W; Gayowski T; Demetris AJ; Gray EA; Flynn B; Zeevi A; Murase N; Starzl TE Transplantation; 2004 Oct; 78(7):966-71. PubMed ID: 15480160 [TBL] [Abstract][Full Text] [Related]
33. Daclizumab and alemtuzumab as induction agents in adult intestinal and multivisceral transplantation: rejection and infection rates in 40 recipients during the early postoperative period. Zanfi C; Lauro A; Cescon M; Dazzi A; Ercolani G; Grazi GL; Zanello M; Vivarelli M; Del Gaudio M; Ravaioli M; Cucchetti A; Vetrone G; Tuci F; Di Gioia P; Lazzarotto T; D'Errico A; Bagni A; Faenza S; Siniscalchi A; Pironi L; Pinna AD Transplant Proc; 2010; 42(1):35-8. PubMed ID: 20172276 [TBL] [Abstract][Full Text] [Related]
34. A randomized trial of alemtuzumab versus antithymocyte globulin induction in renal and pancreas transplantation. Farney AC; Doares W; Rogers J; Singh R; Hartmann E; Hart L; Ashcraft E; Reeves-Daniels A; Gautreaux M; Iskandar SS; Moore P; Adams PL; Stratta RJ Transplantation; 2009 Sep; 88(6):810-9. PubMed ID: 19920781 [TBL] [Abstract][Full Text] [Related]